Kinnate Biopharma Inc. EPS - Earnings per Share 2021-2023 | KNTE
Kinnate Biopharma Inc. eps - earnings per share from 2021 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Kinnate Biopharma Inc. Annual EPS |
| 2023 |
$-2.42 |
| 2022 |
$-2.64 |
| 2021 |
$-2.06 |
| 2020 |
$-5.28 |
| 2019 |
$-2.72 |
| 2018 |
$-2.09 |
| Kinnate Biopharma Inc. Quarterly EPS |
| 2023-12-31 |
$-0.36 |
| 2023-09-30 |
$-0.65 |
| 2023-06-30 |
$-0.68 |
| 2023-03-31 |
$-0.73 |
| 2022-12-31 |
$-0.71 |
| 2022-09-30 |
$-0.70 |
| 2022-06-30 |
$-0.62 |
| 2022-03-31 |
$-0.61 |
| 2021-12-31 |
$-0.60 |
| 2021-09-30 |
$-0.57 |
| 2021-06-30 |
$-0.49 |
| 2021-03-31 |
$-0.40 |
| 2020-12-31 |
$0.64 |
| 2020-09-30 |
$-2.80 |
| 2020-06-30 |
$-2.05 |
| 2020-03-31 |
$-1.07 |
